Xtant Medical Holdings to Present Innovations at Canaccord Genuity Musculoskeletal Conference 2026

Xtant Medical Holdings to Showcase Innovations at Upcoming Musculoskeletal Conference

Xtant Medical Holdings, Inc., a pivotal player in the medical technology sector, announces that its executive team will actively participate in the Canaccord Genuity 2026 Musculoskeletal Conference set for March 2, 2026, in New Orleans. Bringing together key industry stakeholders, this conference primarily focuses on advancements in musculoskeletal health. CEO Sean Browne, CFO Scott Neils, and COO Mark Schallenberger are set to represent the company, highlighting Xtant Medical's commitment to innovation in surgical solutions for spinal, orthopedic, and wound care disorders. The event will provide an accessible virtual platform, ensuring that a broad spectrum of stakeholders can engage with Xtant Medical's endeavors in the field.

Ahead of the conference, Xtant Medical plans to host a webcast presentation on February 2, 2026, at 2:00 PM (ET), offering insights into its latest advancements and innovations. This strategic approach not only underscores the company’s commitment to transparency but also aligns with its mission to improve patient outcomes through innovative solutions. Those interested in further discussion can book one-on-one virtual meetings with Canaccord Genuity representatives, facilitating direct communication between the company and potential investors or partners interested in its comprehensive portfolio of medical technologies.

Xtant Medical emphasizes its commitment to honoring the gift of donation in its operations, a principle central to its ethos of enabling patients to lead fuller lives. The company is renowned for its dedication to developing and commercializing a broad range of products, including orthobiologics for chronic and surgical wound care and advanced spinal implant systems. Operating with integrity and professionalism, Xtant Medical’s workforce reflects a steadfast commitment to enhancing patient outcomes while navigating the competitive medical technology landscape. This mission is detailed on the company's website, where they continue to showcase their innovative solutions and commitment to excellence in the healthcare industry.

In conjunction with its conference participation, Xtant Medical reinforces the importance of its proprietary technologies, which are pivotal in distinguishing the company in a competitive field. By marking this event on their calendar, Xtant Medical not only aims to advance its core objectives but also strengthens its community ties by inviting discussions and collaboration within the medical technology sphere. Following the conference, a replay of the presentation will be accessible for 90 days on Xtant Medical's Investors website, further demonstrating their commitment to keeping stakeholders informed and engaged.